Product How it works Pricing Blog FAQ About Contact
United States

Exponent (NASDAQ: EXPO) stock: the official figures

Exponent (EXPONENT, INC.) is listed on Nasdaq under the ticker EXPO and belongs to the industrials sector. In fiscal 2025 it reported revenue of $582.0m and a net profit of $106.0m, according to the annual accounts it filed with the regulator. Its fiscal year ends on 2 January.

Identifiers for Exponent: SEC CIK 851520.

Fiscal 2025 figures

Consolidated annual accounts of Exponent, in millions of US dollars
Item20252024Change
Revenue$582.0m$558.5m+4.2%
Operating profit$119.8m$119.6m+0.2%
Net profit$106.0m$109.0m−2.7%
Earnings per share$2.08$2.13−2.3%
Operating margin20.6%21.4%−0.8 pts
Net margin18.2%19.5%−1.3 pts
Total assets$777.5m$777.3m0.0%
Equity$390.3m$421.1m−7.3%
Cash$221.9m$258.9m−14.3%
Operating cash flow$131.7m$144.5m−8.9%

Margins are calculated from the filed figures: operating profit and net profit over revenue.

10 fiscal years

Revenue, in millions of US dollars315.12016347.82017379.52018417.22019399.92020466.32021513.32022536.82023558.52024582.02025Net profit, in millions of US dollars47.5201641.3201772.3201882.5201982.62020101.22021102.32022100.32023109.02024106.02025
Fiscal yearRevenueOperating profitNet profitEarnings per shareDocument
2025$582.0m$119.8m$106.0m$2.08Annual report
2024$558.5m$119.6m$109.0m$2.13Annual report
2023$536.8m$111.3m$100.3m$1.96Annual report
2022$513.3m$140.8m$102.3m$1.98Annual report
2021$466.3m$108.9m$101.2m$1.92Annual report
2020$399.9m$83.2m$82.6m$1.58Annual report
2019$417.2m$85.1m$82.5m$1.56Annual report
2018$379.5m$91.5m$72.3m$1.37Annual report
2017$347.8m$72.1m$41.3m$1.57Annual report
2016$315.1m$61.9m$47.5m$1.79Annual report

The full income statement, balance sheet and cash flow statement are in the annual accounts of Exponent. Year by year: dividends paid. Purchases and sales by its executives and directors are in insider transactions.

Dividends

In fiscal 2025, Exponent paid $60.4m in dividends, 57.0% of its net profit, according to its cash flow statement.

Dividends paid by Exponent in each fiscal year, in millions of US dollars
Fiscal yearDividends paidShare of net profit
2025$60.4m57.0%
2024$56.8m52.1%
2023$52.7m52.5%
2022$49.1m48.0%
2021$41.7m41.2%
2020$39.4m47.7%
2019$33.1m40.2%
2018$27.0m37.3%
2017$21.6m52.4%
2016$18.6m39.1%

Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.

Members of Congress who traded Exponent

In the congressional reports read up to 9 November 2026, 2 members have disclosed 5 transactions in Exponent: Jefferson Shreve (3), Lisa C. McClain (2).

Frequently asked questions about Exponent

How much did Exponent earn in fiscal 2025?
Exponent reported a net profit of $106.0m for fiscal 2025, on revenue of $582.0m. The year before it reported a net profit of $109.0m.
Does Exponent pay a dividend?
In fiscal 2025, Exponent paid $60.4m in dividends, 57.0% of its net profit, according to its cash flow statement.
What are the earnings per share of Exponent?
They were $2.08 in fiscal 2025, compared with $2.13 the year before.
Where is Exponent listed?
Exponent is listed on Nasdaq under the ticker EXPO and belongs to the industrials sector.
Where do the figures for Exponent come from?
From the annual report (Form 10-K) that Exponent files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

The annual accounts come from the annual report (Form 10-K) that Exponent files with the SEC, the US securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.

Dividend per share of Exponent by fiscal year, with the filing behind every figure: Exponent dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.